What supplements are appropriate for an adult with non‑scarring hair loss after ruling out nutritional deficiencies?

Supplements for Hair Loss After Ruling Out Nutritional Deficiencies

In adults with non-scarring hair loss and no documented nutritional deficiencies, the evidence does not support routine supplementation, as current data consists primarily of small observational studies and lacks high-quality randomized controlled trials demonstrating meaningful clinical benefit on hair regrowth or quality of life.

Evidence Quality and Limitations

The most comprehensive guideline review 1 examining micronutrients in alopecia areata (a common form of non-scarring hair loss) concludes that while serum vitamin D, zinc, and folate levels tend to be lower in patients with alopecia areata compared to controls, definitive clinical recommendations for routine supplementation cannot be made given the current evidence base consists largely of small case-control studies and case reports 1.

Key Findings by Micronutrient:

Vitamin D:

• Five case-control studies found lower serum 25(OH)D levels in alopecia areata patients 1
• However, the mechanistic role appears related to the vitamin D receptor (VDR) rather than the ligand itself, as mouse studies showed alopecia developed even with adequate vitamin D when VDR was absent 1
• No placebo-controlled trials exist demonstrating that vitamin D supplementation improves hair regrowth in patients without documented deficiency

Iron:

• Evidence is conflicting: only 2 of 8 studies found an association between iron deficiency and alopecia areata 1
• The association was primarily in female patients, not males 1
• Insufficient evidence to recommend screening or supplementation in the absence of documented deficiency 1

Zinc:

• Evidence quality is poor with conflicting results 1
• No high-quality double-blind trials exist using zinc as monotherapy 1

Copper, Magnesium, Selenium:

• Current paucity of studies precludes any conclusions about their role 1

Proprietary Supplement Formulations

A 2023 systematic review 2 identified potential benefit from several proprietary formulations (Viviscal, Nourkrin, Nutrafol, Lamdapil, Pantogar, and others), but this evidence must be interpreted cautiously as:

• Most studies were industry-sponsored
• Sample sizes were small
• Active comparators were lacking
• The specific populations studied may not generalize to all hair loss types

More recent studies 3, 4 from 2026 show improvements in hair parameters with specific supplement combinations, but these are open-label studies without placebo controls, limiting their interpretability.

Clinical Approach

When nutritional deficiencies have been ruled out:

1. Do not routinely recommend micronutrient supplementation as there is no high-quality evidence that supplementation improves hair loss outcomes in the absence of documented deficiency 1

2. If patients insist on supplementation after shared decision-making:

   • Acknowledge that evidence is limited and effects are uncertain
   • Adverse effects are generally rare and mild across studied supplements 2
   • Set realistic expectations that improvement, if any, would take 3-6 months to manifest

3. Focus on evidence-based treatments appropriate to the specific type of hair loss (e.g., minoxidil for androgenetic alopecia, JAK inhibitors for severe alopecia areata 5)

Critical Pitfall

The most common error is assuming that because micronutrients play a role in normal hair follicle function, supplementation will benefit patients without documented deficiency. This logic is not supported by current evidence 1, 6. The hair follicle's requirement for micronutrients does not automatically translate to therapeutic benefit from supraphysiologic supplementation when baseline levels are normal.